These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 119310)

  • 21. Antigenic changes of DBA/2J mastocytoma cells when grown in the BALB/c mouse.
    Wolf JE; Faanes RB; Choi YS
    J Natl Cancer Inst; 1977 May; 58(5):1407-12. PubMed ID: 67213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antimetastatic function of concomitant antitumor immunity. II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells.
    Dye ES
    J Immunol; 1986 Feb; 136(4):1510-5. PubMed ID: 3080526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The blocking activity of antisera raised to either tumor antigens or alloantigens in cytotoxicity assays using syngeneic or allogeneic killer cells on the P815 murine mastocytoma target.
    Al-Rammahy AK; Levy JG
    Cell Immunol; 1980 Dec; 56(2):338-46. PubMed ID: 6781763
    [No Abstract]   [Full Text] [Related]  

  • 24. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.
    Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W
    J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of cytotoxic T cells by nonstimulating tumor cells and spleen cell factor(s).
    Talmage DW; Woolnough JA; Hemmingsen H; Lopez L; Lafferty KJ
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4610-4. PubMed ID: 303772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated cytotoxicity to chemically-induced rat tumours.
    Zöller M; Price MR; Baldwin RW
    Int J Cancer; 1975 Oct; 16(4):593-606. PubMed ID: 170224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmentation of antigen-specific cytotoxicity by concanavalin A at the peak of response to tumor allografts.
    Shimamoto Y; Nomoto K; Taniguchi K; Kubo C
    Cell Immunol; 1979 Sep; 47(1):204-10. PubMed ID: 92366
    [No Abstract]   [Full Text] [Related]  

  • 28. Cell-mediated cytotoxic responses induced in vivo and in vitro by a metastatic murine tumor.
    Wiltrout RH; Frost P
    J Immunol; 1980 May; 124(5):2254-63. PubMed ID: 7365255
    [No Abstract]   [Full Text] [Related]  

  • 29. Specific cytostatic effect of lymph node cells from normal and T cell-deficient mice on syngeneic tumor target cells in vitro and its specific abrogation by body fluids from syngeneic tumor-bearing mice.
    Chia E; Festenstein H
    Eur J Immunol; 1973 Aug; 3(8):483-7. PubMed ID: 4543175
    [No Abstract]   [Full Text] [Related]  

  • 30. Solubilized tumour-associated antigens of methyl-cholanthrene-induced mouse sarcomas. Comparative studies by in vitro sensitization of lymph-node cells, macrophage electrophoretic mobility assay and transplantation tests.
    Bubeník J; Indrová M; Nemecková S; Malkovský M; Von Broen B; Pálek V; Anderlíková J
    Int J Cancer; 1978 Mar; 21(3):348-55. PubMed ID: 75857
    [No Abstract]   [Full Text] [Related]  

  • 31. Recovery of activated cytotoxic T cells from minor H incompatible tumor graft rejection sites.
    Ksander BR; Streilein JW
    J Immunol; 1989 Jul; 143(2):426-31. PubMed ID: 2500481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells.
    Gillis S; Smith KA
    J Exp Med; 1977 Aug; 146(2):468-82. PubMed ID: 69003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition by lymphoid cellular factors of the immunological cytotoxicity against a syngeneic tumour.
    Lafontaine N; Firket H
    Pathol Eur; 1976; 11(2):147-50. PubMed ID: 958732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity.
    Herberman RB; Nunn ME; Lavrin DH
    Int J Cancer; 1975 Aug; 16(2):216-29. PubMed ID: 50294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the mechanism of lymphocyte-mediated cytolysis. X. Enucleated cells as targets for cytotoxic attack.
    Siliciano RF; Henney CS
    J Immunol; 1978 Jul; 121(1):186-91. PubMed ID: 97346
    [No Abstract]   [Full Text] [Related]  

  • 37. Separation of lymphoid cells with a suppressor effect on the activity of cytotoxic cells in vitro during the growth of a syngeneic mouse tumour.
    Schaaf-Lafontaine N
    Int J Cancer; 1978 Mar; 21(3):329-33. PubMed ID: 631933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Lyt phenotype of cells involved in the cytotoxic response to syngeneic tumor and of tumor-specific suppressor cells.
    Maier T; Levy JG; Kilburn DG
    Cell Immunol; 1980 Dec; 56(2):392-9. PubMed ID: 6451300
    [No Abstract]   [Full Text] [Related]  

  • 39. Clones of cytotoxic lymphocytes in culture: the difference in specificity between stimulated and nonstimulated cytotoxic lymphocytes.
    Ching LM; Walker KZ; Marbrook J
    Eur J Immunol; 1977 Dec; 7(12):846-50. PubMed ID: 147175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helper cells active in the generation of cytotoxicity to a syngeneic tumor.
    Hancock EJ; Kilburn DG; Levy JG
    J Immunol; 1981 Oct; 127(4):1394-7. PubMed ID: 6168688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.